Purchase order 4800221119

The University of Nebraska Medical Center (UNMC), a state institution located in Omaha, Nebraska, awarded a purchase order (PO 4800221119) to Cell Signaling Technology Inc., a Boston, Massachusetts-based vendor, on July 28, 2026. The contract encompasses the procurement of one unit of Caspase-3 Antibody (material number 9662S), a research-grade biological reagent, for a total contract value of $317. The period of performance spans from the award date of July 28, 2026, through the scheduled delivery date of August 4, 2026. Delivery is designated for UNMC General Supply at 601 South Saddle Creek Road, Omaha, Nebraska 68106.

The purchase order is governed by the Standard Terms of Purchase established by the University of Nebraska Board of Regents and includes standard commercial terms including Net 30 payment terms and Free on Board (FOB) destination with freight prepaid. The vendor is required to acknowledge acceptance of the purchase order within ten days of issuance. As a state institution, UNMC maintains tax-exempt status and operates through the ARIBA Procure-to-Pay (P2P) ordering system. All invoicing and supporting documentation must reference the purchase order number to facilitate prompt payment processing.